Pegloticase - New Drug For Gout
Links shared publicly online about this topic.
- 34total visits
Pegloticase - New Drug For Gout
View full resource at disabled-world.com
Tags: Arthritis, Crystal Disorders, Gout, Drug
Most Recently Shared on August 30, 2011 at 9:00 pm By:
#Pegloticase - New Drug For #Gout http://t.co/83tWQ7u
Takeda to Acquire URL Pharma - Drugs.com MedNews
drugs.com — “Acquisition Expands U.S. Business, Leadership in Gout DEERFIELD, Ill., OSAKA, Japan, and PHILADELPHIA, April 11, 2012 Takeda Pharmaceutical Company Limited (Tak” View full resource at drugs.com
Most Recently Shared on April 11, 2012 at 1:02 pm By:
Drugs and Devices OW OW Health
Takeda to Acquire URL Pharma: Acquisition Expands U.S. Business, Leadership in Gout DEERFIELD, Ill., OSAKA... http://t.co/Vvc5FeMM #drug
Drug may help gout patients stick to long-tem therapy | Gritman Medical Center |
gritman.netreturns.biz — “Drug may help gout patients stick to long-tem therapy | Gritman Medical Center |” View full resource at gritman.netreturns.biz
Most Recently Shared on January 15, 2012 at 2:00 pm By:
"Drug may help gout patients stick to long-tem therapy" http://t.co/YagVZSJf
Drug Eases Gout Flare-ups in Some Patients - HealthNewsReview.org
healthnewsreview.org — “Drug Eases Gout Flare-ups in Some Patients - HealthNewsReview.org” View full resource at healthnewsreview.org
Most Recently Shared on January 6, 2012 at 10:09 pm By:
HealthDay story on gout drug gets only 1 star. Why? Lifts quotes from news release, doesn't discuss harms, etc. - http://t.co/xoNLmSPu
Gout Flares - Rilonacept Effective, According To Clinical Trial
medicalnewstoday.com — “According to a phase II clinical trial, the drug rilonacept, which inhibits the protein interleukin-1 (IL-1), substantially reduces acute gout flares that occur at the start of uric acid-reducing” View full resource at medicalnewstoday.com
Most Recently Shared on January 6, 2012 at 8:20 pm By:
Dr. Frederic Vagnini Doctor, Surgeon, and Physician
Gout Flares - Rilonacept Effective, According To Clinical Trial http://t.co/iNWB2DNr via @mnt_gout
Gout Drug Reduces Incidence of Irregular Heartbeat After Surgery - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Study Highlights:” View full resource at finance.yahoo.com
Most Recently Shared on November 16, 2011 at 1:25 pm By:
Gout Drug Reduces Incidence of Irregular Heartbeat After Surgery: Study Highlights: http://t.co/Q7NRqPZ2
Medical News: FDA Denies Biologic for Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 31, 2011 at 5:43 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: FDA Denies Biologic for Gout - http://t.co/q8GIQSx from @medpagetoday #health #medicine
FDA Denies Biologic for Gout - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at qualitypointtech.net
Most Recently Shared on August 29, 2011 at 9:45 pm By:
FDA Denies Biologic for Gout: (MedPage Today) -- The FDA declined to approve canakinumab (Ilaris) for treating gou... http://t.co/IPHvEU3
Medical News: FDA Denies Biologic for Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 9:37 pm By:
FDA Denies Biologic for Gout http://t.co/dOtLQL3
FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis | Reuters
reuters.com — “Novartis International AG / FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis . Processed and transmitted by Thomson Reuters ONE. The i” View full resource at reuters.com
Most Recently Shared on August 29, 2011 at 11:03 am By:
John Carroll Health Communicator
Novartis gets a CRL demanding more data on ACZ885 for gouty arthritis. http://t.co/8vT5noP
Medication for severe, chronic gout associated with improvement in symptoms
labspaces.net — “As an alternative to a conventional treatment for gout that some patients may not respond to, patients with severe, chronic gout who received the medication pegloticase for 6 months had greater improvement in measures of uric acid levels as well as physical function and quality of life, according to a study in the August 17 issue of JAMA.” View full resource at labspaces.net
Most Recently Shared on August 18, 2011 at 1:00 pm By:
Medication for severe, chronic gout associated with improvement in symptoms - http://t.co/eT4NolR
Rheumatology Article | Gout
mdlinx.com — “Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: Two randomized controlled trials” View full resource at mdlinx.com
Most Recently Shared on August 18, 2011 at 6:05 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory ... http://t.co/yxcK58V #Rheumatology
Medical News: Enzyme Works for Hard-to-Treat Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The intravenous enzyme pegloticase (Krystexxa) is an effective therapy for many people whose gout doesn't respond to conventional treatment, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on August 17, 2011 at 7:00 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Enzyme Works for Hard-to-Treat Gout - in Rheumatology, General Rheumatology from MedPage Today - http://t.co/YCb597R from @medpagetoday
Savient Pharmaceuticals Announces Publication of Pivotal Phase III Krystexxa Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients - Drugs.com MedNews
drugs.com — “Pooled data from two Phase III studies demonstrated that 42 percent of refractory chronic gout (RCG) patients treated with KRYSTEXXA every two weeks achieved st” View full resource at drugs.com
Most Recently Shared on August 17, 2011 at 4:16 pm By:
Drugs and Devices OW OW Health
Savient Pharmaceuticals Announces Publication of Pivotal Phase III Krystexxa Data in JAMA Demonstrating Si... http://t.co/fbOgYy5 #drug
Pegloticase, Alternative Treatment For Chronic Gout Shows Greater Improvement In Symptoms
medicalnewstoday.com — “According to a study in the August 17 issue of JAMA, patients with severe, chronic gout who took pegloticase for 6 months as an alternative to conventional gout treatment that some patients” View full resource at medicalnewstoday.com
Most Recently Shared on August 17, 2011 at 4:05 pm By:
MNT - Comp Medicine Health News
Pegloticase, Alternative Treatment For Chronic Gout Shows Greater Improvement In Symptoms http://mnt.to/3Z2d #complementarymedicine
Pegloticase Helps Patients With Severe, Chronic Gout
medicalnewstoday.com — “Individuals with severe, chronic gout who have not responded to conventional treatment may benefit from six-months' worth of pegloticase treatment. Researchers from Duke University Medical Center,” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2011 at 10:05 pm By:
Pegloticase Helps Patients With Severe, Chronic Gout http://mnt.to/3YYT #gout
Advertisement
